National Institute of Allergy and Infectious Diseases, National Institutes of Health

Help | Site Index | Contact Us

NIAID Research Funding

NIAID Funding News

Opportunities and Announcements

Budget and Funding

Grants

Contracts
About NIAID Contracts
Requests for Proposals
Standard Operating Procedures
Contracts Links
Training and Career
Contact Information

Standard Operating Procedures

Questions and Answers

Advisory Council

Glossary of Funding and Policy Terms

Find It! A-Z

Latest Updates

Archived RFPs and Amendments -- 2003

ID No.	Full RFP Number, Title, and Amendments	Open Date	Close Date
04-06	RFP-NIH-NIAID-DAIT-04-06, Atopic Dermatitis and Vaccinia Immunization Network: Clinical Studies Consortium	2003-04-18	2003-07-28
04-07	RFP-NIH-NIAID-DAIT-04-07, Atopic Dermatitis and Vaccinia Immunization Network: Animal Studies Consortium	2003-04-18	2003-07-28
04-08	RFP-NIH-NIAID-DAIT-04-08, Atopic Dermatitis and Vaccinia Immunization Network: Statistical and Data Coordinating Center Amendment #1, Q&A, 2003-07-14	2003-04-18	2003-07-28
04-09	RFP-NIH-NIAID-DMID-04-09, Sexually Transmitted Infections Clinical Trials Group Amendment #1, 2003-08-20 Amendment #2, 2003-09-10 Amendment #3, 2003-09-22	2003-06-13	2003-09-24
04-10	RFP-NIH-NIAID-DMID-04-10, Malaria Vaccines: Clinical Research & Trial Sites in Endemic Areas	2003-03-25	2003-09-18
04-17	RFP-NIH-NIAID-DMID-04-17, Development, Testing and Evaluation of Candidate Vaccines Against Plague Amendment #1, 2003-11-19 Amendment #2, Q&A, 2003-11-19	2003-08-06	2003-12-03
04-18	NIH-NIAID-DAIT-BAA-04-18, Population Genetics Analysis Program: Immunity to Vaccines/Infections	2003-10-15	2004-01-15
04-21	RFP-NIH-NIAID-DMID-04-21, Tuberculosis Vaccine Testing and Research Materials Amendment #1, 2003-11-18 Amendment #2, 2003-12-09 Amendment #3, 2004-01-30	2003-09-08	2004-02-06
04-22	RFP-NIH-NIAID-DMID-04-22, Assessing Safety of Cell Substrates and Vaccine Components Amendment #1, Q&A, 2004-02-10	2003-11-24	2004-03-01
04-23	RFP-NIH-NIAID-DAIDS-04-23, Master Contract for Preclinical Development Amendment #1, 2003-07-11 Amendment #2, 2003-07-24	2003-04-04	2003-08-19
04-24	RFP-NIH-NIAID-DAIT-04-24, Development of Immune Monitoring Reagents and MHC Typing Technologies for Non-Human Primates Amendment #1, 2003-11-26 Amendment #2, Q&A, 2004-02-10	2003-11-20	2004-03-01
04-30	RFP-NIH-NIAID-DAIDS-04-30, Patient Safety Monitoring in International Laboratories	2003-12-17	2004-03-15
04-34	RFP-NIH-NIAID-DMID-04-34, Bioinformatics Resource Centers for Biodefense and Emerging/Re-emerging Infectious Diseases Amendment #1, 2003-04-08 Amendment #2, Q&A, revised 2003-05-15 Amendment #3, 2003-05-28	2003-02-11	2003-06-25
04-38	RFP-NIH-NIAID-DAIT-BAA-04-38, Innate Immune Receptors and Adjuvant Discovery Amendment #1, 2003-08-22	2003-06-27	2003-10-06
04-39	RFP-NIH-NIAID-DAIT-04-39, Large Scale Antibody and T Cell Epitope Discovery Program	2003-10-10	2004-01-15
04-40	RFP-NIH-NIAID-DMID-04-40, In Vitro and Animal Models for Emerging Infectious Diseases and BioDefense Amendment #1, 2003-12-29 Amendment #2, Q&A, 2004-02-18	2003-12-16	2004-03-01
04-42	RFP-NIH-NIAID-DAIDS-04-42, HIV Vaccine Design and Development Teams Amendment #1, 2003-12-03 Amendment #2, 2003-12-16 Amendment #3, Q&A, 2003-12-16	2003-11-24	2004-02-19
04-43	RFP-NIH-NIAID-DAIT-04-43, Administrative Support Contract for DAIT Clinical Research Programs Amendment #1, 2003-12-17 Amendment #2, Cancellation, 2004-01-05	2003-12-04	CANCELLED
04-44	RFP-NIH-NIAID-DAIT-04-44, Regulatory Management Center -- DAIT Amendment #1, 2003-12-17 Amendment #2, Q&A, 2004-01-21	2003-12-04	2004-02-17
04-45	RFP-NIH-NIAID-DAIT-04-45, Clinical Products Distribution Center -- DAIT Amendment #1, 2003-12-17	2003-12-04	2004-02-10
04-46	RFP-NIH-NIAID-DAIT-04-46, Immune Tolerance Network -- Clinical Site Monitoring Group Amendment #1, 2003-12-17 Amendment #2, Q&A, 2004-02-05	2003-12-05	2004-02-24
04-49	RFP-NIH-NIAID-DMID-04-49, Production and Testing of a Modified Vaccinia Ankara Vaccine	2003-12-04	2004-02-04
03-29	RFP-NIH-NIAID-DMID-03-29, Production and Testing of Anthrax Recombinant Protective Antigen (rPA) Vaccine Amendment #1, 2003-06-09 Amendment #2, 2003-06-11 Amendment #3, 2003-06-17	2003-05-23	2003-07-01
03-54	RFP-NIH-NIAID-DMID-03-54, Construction Quality Management (CQM) Support Services Amendment #1, 2003-01-24	2003-01-24	2003-02-24

For other years, see the archived RFPs index. You can also see current RFPs.

Return to the main R&D Contracts Web page.

Department of Health and Human Services

National Institutes of Health

National Institute of Allergy and Infectious Diseases

November 10, 2004